Palynziq Clinical Trials (2026): 2 Studies for Phenylketonuria & Phenylketonurias
Hipa.ai Research · Source: ClinicalTrials.gov / AACT
Synced daily from ClinicalTrials.gov via AACT. Last sync: .
2 Palynziq clinical trials are catalogued on Hipa.ai from the AACT mirror of ClinicalTrials.gov, spanning 2 indications (including Phenylketonuria & Phenylketonurias) and 54 total planned enrollment. 1 Palynziq clinical trial is actively recruiting at 2 U.S. sites across 1 state. Most recent activity: NCT04404530 (Dec 2028).
Where to Participate: All Palynziq Trial Sites in the U.S. (2 sites across 1 state)
Every actively recruiting Palynziqtrial site, sorted by state then city. Each row links to the trial detail page (eligibility, contacts, full study record). Sites no longer enrolling at the location level are excluded. ClinicalTrials.gov / AACT does not provide street-level addresses; the map link uses the facility's geocoded coordinates where available.
| State | Facility | City | Trial | Map |
|---|---|---|---|---|
| GA | Emory University Hospital Georgia Clinical Research Center | Atlanta30322 | NCT04404530 | Map |
| GA | The Emory Clinic | Atlanta30322 | NCT04404530 | Map |
Palynziq clinical trials at a glance: phase × recruitment status
| Phase | recruiting | active not recruiting | Total |
|---|---|---|---|
| P4 | 1 | 1 | |
| N/A | 1 | 1 |
Recruiting Palynziq clinical trials (1)
Studies currently enrolling participants. Click any NCT ID to view the trial detail page (eligibility, sites, contacts).
| NCT ID | Title | Phase | Indication | Enrollment | Started |
|---|---|---|---|---|---|
| NCT04404530 | PKUNutritional Impacts of Palynziq on Patients With Phenylketonuria (PKU) | — | Phenylketonurias | 45 | Oct 2019 |
Palynziq clinical trials by indication
Phenylketonuria (1)
| NCT | Acronym | Phase | Status | Title |
|---|---|---|---|---|
| NCT06780332 | PALLADIUM | P4 | active not recruiting | Rapid Drug Desensitization Study in Adults Experiencing Hypersensitivity Reactions to Palynziq |
Phenylketonurias (1)
| NCT | Acronym | Phase | Status | Title |
|---|---|---|---|---|
| NCT04404530 | PKU | N/A | recruiting | Nutritional Impacts of Palynziq on Patients With Phenylketonuria (PKU) |
Palynziq pivotal trial highlights (Phase 2/3/4)
Phase-2/3/4 studies with named acronyms — the registration-grade trials most cited in label discussions and Wikipedia.
| Acronym | NCT | Phase | Status | Indication | Enrollment | PubMed |
|---|---|---|---|---|---|---|
| PALLADIUM | NCT06780332 | P4 | active not recruiting | Phenylketonuria | 9 | — |
All Palynziq trials (2)
Sorted by most recent activity (completion → start → posted date). Each row links to the trial detail page on Hipa.ai.
| NCT ID | Acronym | Title | Phase | Status | Enrollment | Sponsor | Started |
|---|---|---|---|---|---|---|---|
| NCT04404530 | PKU | Nutritional Impacts of Palynziq on Patients With Phenylketonuria (PKU) | — | recruiting | 45 | Emory University | Oct 2019 |
| NCT06780332 | PALLADIUM | Rapid Drug Desensitization Study in Adults Experiencing Hypersensitivity Reactions to Palynziq | P4 | active not recruiting | 9 | BioMarin Pharmaceutical | Feb 2025 |
Palynziq clinical trials: frequently asked questions
- How many Palynziq clinical trials are there?
- 2 Palynziq clinical trials are catalogued on Hipa.ai, sourced from the AACT mirror of ClinicalTrials.gov. 1 is actively recruiting participants.
- Are Palynziq clinical trials recruiting in 2026?
- Yes — 1 Palynziq trial is actively recruiting in 2026, with 2 U.S. sites across 1 state. See the recruiting trials and the per-state site list further down this page.
- What conditions is Palynziq being studied for?
- Palynziq is being studied for Phenylketonuria, Phenylketonurias, PKU. The trials are grouped by indication on this page.
- What phase is Palynziq in?
- Palynziq clinical trials span 1 Phase 4. The phase × status matrix at the top of this page breaks down counts by phase and recruitment status.
- Who sponsors Palynziq clinical trials?
- The lead sponsor across the most Palynziq trials is BioMarin Pharmaceutical, with 1 additional lead sponsor listed in the data. Each trial row links to the full study detail page including sponsor information.
Sources and methodology
Trial inventory derived from the AACT mirror of ClinicalTrials.gov. Trials are filtered to those naming Palynziqas an intervention. Phase, status, enrollment, sponsor, and dates are taken from the source `studies` table; primary indication is the first listed condition. Acronyms are extracted from each trial's brief title where present. PubMed links are populated for trials whose published primary outcomes have been indexed in our evidence cache.
Last refreshed .
Related pages on Hipa.ai: